Metabolomics and bladder cancer (Q37935192)

25 August 2017

Metabolomics and bladder cancer (English)

1 reference

25 August 2017

1 reference

Matthew E Hyndman

1

1 reference

PubMed ID

21930087

25 August 2017

Jeffrey K Mullins

series ordinal

2

1 reference

PubMed ID

21930087

25 August 2017

Trinity J Bivalacqua

series ordinal

3

1 reference

25 August 2017

1 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

29

1 reference

25 August 2017

558-561

1 reference

25 August 2017

5

1 reference

25 August 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Histopathological aspects of transitional cell carcinoma of the bladder: analysis of 20 years experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Analytical approaches to metabolomics and applications to systems biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Molecular causes of the aberrant choline phospholipid metabolism in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Noninvasive urinary metabonomic diagnosis of human bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

High-resolution 1H NMR spectroscopy in the diagnosis of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinning-nuclear magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1H NMR spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Olfactory detection of human bladder cancer by dogs: another cancer detected by "pet scan".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

Olfactory detection of human bladder cancer by dogs: proof of principle study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.05.014

10.1016/J.UROLONC.2011.05.014

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21930087